American Society of Clinical Oncology

SHERPA: White

People

  1. Schultz
    Schultz
  2. Solit
    Solit
  3. Berger
    Berger
  4. Ladanyi
    Ladanyi
  5. Chatila
    Chatila
  6. Arcila
    Arcila
  7. Ilson
    Ilson
  8. Kundra
    Kundra
  9. Ku
    Ku
  10. Janjigian
    Janjigian

Groups

  1. Computational Oncology Service (43)
  2. Department of Medicine (43)
  3. Epidemiology and Biostatistics (43)
  4. GSK Faculty (43)
  5. Genitourinary Oncology Service (43)
  6. Human Oncology and Pathogenesis Program (43)
  7. Solid Tumor Oncology Division (43)
  8. Surgery (24)
  9. Gastrointestinal Oncology Service (22)
  10. Sloan Kettering Institute Postdocs (21)
Search Within
  1. "David Solit"
  2. "Solid Tumor Oncology Division"
  3. "Nikolaus Schultz"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (11)
Groups
  1. Computational Oncology Service (43)
  2. Department of Medicine (43)
  3. Epidemiology and Biostatistics (43)
  4. GSK Faculty (43)
  5. Genitourinary Oncology Service (43)
  6. Human Oncology and Pathogenesis Program (43)

More Groups

People
  1. David Solit (43)
  2. Nikolaus Schultz (43)
  3. Michael Berger (29)
  4. Jaclyn Hechtman (14)
  5. Marc Ladanyi (14)
  6. Yelena Janjigian (14)

More People

Years
  1. 2023 (5)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (7)
  6. 2018 (7)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. JCO Precision Oncology (5)
  3. JCO Clinical Cancer Informatics (1)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Barnett, E.; Schonhoft, J.; Schultz, N. D.; Lee, J.; Zaidi, S.; Abida, W.; Carmichael, T.; Dago, A. E.; Solit, D. B.; Wenstrup, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
    Journal Article

    Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts)
    Meeting Abstract

    Scher, H. I.; Lee, J.; Dago, A. E.; Barnett, E.; Sutton, R.; Carbone, E.; Schreiber, N. A.; Hullings, M.; Ebrahim, N.; Landers, M. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save